Catalyst
Key milestones include interim safety reports and final results from the registry after the 10-year follow-up.
Humanexa recommends Monitor.
Date
July 20, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.